Analyst Ratings for Infinity Pharmaceutical (INFI) [Neutrals]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/24/2023 | Piper Sandler | Edward Tenthoff | Downgrade | Neutral (Overweight) |
0.30 (3.00) |
0.55 (0.04) |
-92.73% | Details |
11/15/2022 | B.Riley | Pharm Patel | Downgrade | Neutral (Buy) |
1.50 (N/A) |
0.74 (0.04) |
-94.59% | Details |